The Clinical Trial as Unintended Katabasis: Strassman’s Volunteers Descend Without a Myth

Rick Strassman’s five-year program of intravenous DMT administration at the University of New Mexico (1990–1995) was the first federally approved psychedelic research in the United States in over two decades. The book that emerged from it reads, on the surface, as a clinician’s memoir: regulatory battles, dosing protocols, vital-sign charts. But the gravitational center of the text is not methodology. It is the volunteer reports—accounts of entity contact, dissolution of selfhood, encounters with geometric intelligences, landscapes of jeweled light, and confrontations with death that resist every interpretive frame Strassman attempts to impose. What the book documents, without fully recognizing it, is a clinical katabasis: a descent into underworld experience conducted inside a hospital room, stripped of ritual container, mythic narrative, and initiatory return. Hillman’s insistence that “dreaming is the psyche itself doing its soul-work” applies with force here: DMT vaporizes the dayworld ego and plunges subjects into imaginal terrain, yet the research design offers no vessel for what the psyche produces. The volunteers encounter what depth psychology would call archetypal dominants—beings, thresholds, annihilation experiences—but the clinical setting translates these into “adverse reactions” or “unusual subjective effects.” The absence of a hermeneutic framework is not incidental; it is the book’s defining tension.

Strassman’s Pineal Hypothesis Resurrects the Cartesian Soul-Organ That Depth Psychology Buried

The book’s most publicized claim—that endogenous DMT, synthesized in the pineal gland, mediates birth, death, and mystical experience—is both its boldest gesture and its most revealing limitation. Strassman explicitly invokes Descartes’s identification of the pineal as the seat of the soul, updating it with speculative endocrinology. This is not a minor rhetorical flourish. It recapitulates the very dualism that depth psychology, from Freud through Jung to Hillman, labored to overcome. Hillman argued in Re-Visioning Psychology that “the soul is ceaselessly talking about itself in ever-recurring motifs” and cannot be confined to a single organ, a single substance, or a single explanatory register. Marie-Louise von Franz, critiquing the McKenna brothers’ hallucinogenic experiments in her discussion of active imagination, noted that drug-induced visions yielded “nothing creative and new, but only things that the well-read authors could just as easily have thought up consciously”—a judgment aimed not at the visions themselves but at the absence of the ego’s active, ethical engagement with the material. Strassman’s pineal hypothesis performs a similar reduction: it takes the irreducible multiplicity of psychedelic phenomenology and funnels it into a single molecular mechanism, as if naming the neurotransmitter resolves the ontological question. The spirit molecule becomes a literalism—a biochemical idol—that forecloses the very mystery it claims to honor. What Strassman calls “the biology of mystical experience” is, in Hillman’s terms, a dayworld translation that domesticates the underworld.

The Missing Fourth Step: Why Pharmacology Without Soul-Work Produces Data but Not Transformation

Von Franz’s critique of drug-facilitated imagination centers on what she calls the missing “fourth step”—the moment when the ego must actively wrestle with, respond to, and take ethical responsibility for the images that arise. In active imagination as Jung practiced it, the patient who encounters a wall must find her own way through; the analyst does not intervene, because the struggle is the transformation. Strassman’s protocol, by design, eliminates this step. Volunteers lie on a hospital bed, receive an injection, and report what they see to a researcher holding a clipboard. The encounter is observed, not engaged. Greg Mahr’s contemporary clinical work with psychedelics, informed by Jungian depth psychology, demonstrates the alternative: a guided framework in which the “trip ego” functions analogously to the dream ego, supported by a guide who assumes the archetypal role of psychopomp. Mahr’s insight that “hallucinogens, by destabilizing the DMN, give access to an inner world like that experienced in active imagination” identifies precisely what Strassman’s protocol lacks—not the pharmacological agent but the relational and imaginal container that allows the psyche’s productions to become soul-making rather than mere phenomenological data. Strassman himself senses this gap; his later chapters veer into Buddhist cosmology and Hebrew mysticism, searching for a framework adequate to what his volunteers reported. But the search remains eclectic and unmoored, because the clinical paradigm has no native language for the numinous.

The Spirit Molecule as Symptom of the Modern Impasse Between Science and the Sacred

Richard Tarnas’s diagnosis of modernity’s “seemingly irresolvable tension of opposites” between “an objectivist cosmology and a subjectivist psychology” finds no better case study than Strassman’s project. The DMT research sits precisely at the fracture line. The experiences are subjectively overwhelming—volunteers weep, report contact with autonomous intelligences, describe ego death in language indistinguishable from classical mystical literature. Yet the institutional framework demands that these be coded as pharmacological effects, reducible to receptor binding and serotonergic modulation. Strassman, to his credit, refuses full reduction; he speculates, reaches toward metaphysics, admits bewilderment. But he cannot bridge the gap because, as Tarnas argues, “within the established structure of the modern world view, no matter how subjectively convincing might be the psychological evidence for a transcendent spiritual dimension… the discoveries of psychology could reveal nothing with certainty about the actual constitution of reality.” Campbell’s earlier encounter with Grof’s LSD research produced a similar recognition: the transpersonal experiences mapped cleanly onto mythological structures, but the scientific context could only register them as “reactions.” Strassman’s book is valuable not because it resolves this impasse but because it enacts it with unusual transparency—a scientist who opens a door he has no philosophical architecture to walk through.

What makes DMT: The Spirit Molecule irreplaceable for anyone working at the intersection of psyche and matter is not its pharmacology, which remains speculative, nor its theology, which remains improvised. It is the raw phenomenological archive—hundreds of pages of first-person accounts of encounters with autonomous psychic realities, generated under controlled conditions, that no existing paradigm fully accounts for. The book stands as a monument to what happens when empirical science produces numinous data it cannot metabolize. For readers formed by depth psychology, it is an invitation not to answer Strassman’s questions but to reframe them entirely: the spirit molecule is not in the pineal gland. It is in the relationship between the ego and the images that shatter it.